Literature DB >> 4672467

Action of 1- -D-arabinofuranosylcytosine on mammalian tumor cells. 1. Incorporation into DNA.

R K Zahn, W E Müller, W Forster, A Maidhof, R Beyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4672467     DOI: 10.1016/0014-2964(72)90122-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

Review 1.  High-dose cytosine arabinoside: pharmacological and clinical aspects.

Authors:  W G Peters; L P Colly; R Willemze
Journal:  Blut       Date:  1988-01

2.  Effect of arabinosyl cytosine on the level of DNA polymerase and thymidine kinase activity in PHA-stimulated human tonsillar lymphocytes.

Authors:  M Staub; M Sasvári-Székely; T Spasokukockaja; F Antoni
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

3.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

4.  Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.

Authors:  P P Major; E M Egan; G P Beardsley; M D Minden; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

5.  Traditional and Modern Biomedical Prospecting: Part II-the Benefits: Approaches for a Sustainable Exploitation of Biodiversity (Secondary Metabolites and Biomaterials from Sponges).

Authors:  Werner E G Müller; Heinz C Schröder; Matthias Wiens; Sanja Perović-Ottstadt; Renato Batel; Isabel M Müller
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

6.  Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia.

Authors:  S E Fordham; M Cole; J A Irving; J M Allan
Journal:  Leukemia       Date:  2014-09-24       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.